Gene · 5339
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promoting the adhesion of human gingival epithelial cells on titanium surface by non-thermal atmospheric plasma irradiation. | Hua Xi Kou Qiang Yi Xue Za Zhi | 2022 | 38597008 | PubTator, text mining | PubMed |
| New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma. | Front Oncol | 2022 | 36776379 | PubTator, text mining | PubMed |
| Case report: Fatal infantile hypertonic myofibrillar myopathy with compound heterozygous mutations in the CRYAB gene. | Front Pediatr | 2022 | 36727013 | PubTator, text mining | PubMed |
| A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy. | Front Genet | 2022 | 36699444 | PubTator, text mining | PubMed |
| Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics. | Front Immunol | 2022 | 36685489 | PubTator, text mining | PubMed |
| Factors Regulating Fluid Restitution and Plasma Volume Reduction over the Course of Hemodialysis. | Toxins (Basel) | 2022 | 36668851 | PubTator, text mining | PubMed |
| Expression of risk genes linked to vitamin D receptor super-enhancer regions and their association with phenotype severity in multiple sclerosis. | Front Neurol | 2022 | 36644209 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling. | Int J Mol Sci | 2022 | 36613607 | PubTator, text mining | PubMed |
| Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling. | Int J Mol Sci | 2022 | 36613521 | PubTator, text mining | PubMed |
| Regulation of Kinase Signaling Pathways by α6β4-Integrins and Plectin in Prostate Cancer. | Cancers (Basel) | 2022 | 36612146 | PubTator, text mining | PubMed |
| Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. | Front Mol Neurosci | 2022 | 36590916 | PubTator, text mining | PubMed |
| Mutational analysis of epidermolysis bullosa in Taiwan by whole-exome sequencing complemented by RNA sequencing: a series of 77 patients. | Orphanet J Rare Dis | 2022 | 36578049 | PubTator, text mining | PubMed |
| Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy. | Clin Epigenetics | 2022 | 36575526 | PubTator, text mining | PubMed |
| Plasma polymerized bio-interface directs fibronectin adsorption and functionalization to enhance "epithelial barrier structure" formation via FN-ITG β1-FAK-mTOR signaling cascade. | Biomater Res | 2022 | 36572920 | PubTator, text mining | PubMed |
| Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (TP53) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach. | Int J Mol Sci | 2022 | 36555140 | PubTator, text mining | PubMed |
| Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases. | Int J Mol Sci | 2022 | 36555098 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms. | Cells | 2022 | 36552803 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Vimentin-Induced Disruption of Cell-Cell Associations Augments Breast Cancer Cell Migration. | Cells | 2022 | 36552797 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5339/papers?page=21